In vitro effects of aldosterone have been described with regard to the intracellular sodium and potassium concentrations of human mononuclear leukocytes. In the present paper the in vitro effect of aldosterone on the intracellular sodium and potassium of human mononuclear leukocytes in 6 patients with primary aldosteronism was investigated. Except for one patient with elevated intracellular electrolytes, sodium and potassium in mononuclear leukocytes of patients with aldosteronism without incubation were within the range for normals. In the patients, no significant change of intracellular sodium or potassium was observed during incubation with or without aldosterone (1.4 nmol/l), whereas in normals, the loss of sodium and potassium during incubation without aldosterone was prevented by 1.4 nmol/l aldosterone. This insensitivity to aldosterone indicates that intracellular electrolytes in mononuclear leukocytes of patients with primary aldosteronism are kept in normal ranges by mechanism which are independent of mineralocorticoids and may represent the cellular correlate to the renal 'escape' phenomenon in aldosteronism.Recently, mineralocorticoid receptors and effects of aldosterone on intracellular (ic) sodium and potassium have been described for human mononuclear leukocytes (HML) (Armanini et al. 1985a;Wehling et al. 1987). The use of HML appears to provide an easily accessible model for studying the possible physiological effects of aldosterone bind¬ ing to type I receptors with regard to ic electro¬ lytes in vitro.The clinical significance of these receptors was underlined by the demonstration of absent or a decreased number of mineralocorticoid receptors and the lack of electrolyte response to aldosterone in HML of patients with pseudohypoaldosteronism (Armanini et al. 1985b; Wehlingetal. 1986).For patients with primary and secondary aldo¬ steronism, a reduced number of mineralocorti¬ coid receptors has been shown on HML (Armani¬ ni et al. 1987), thus indicating a 'down-regulation' in response to chronically elevated serum levels of aldosterone. It was hypothesized that this downregulation contributes to the 'escape' not only of HML, but also of renal tubular cells, from mine¬ ralocorticoid effects which opposes the develop¬ ment of more severe sodium retention and hypokalaemia in these patients. To further study the physiological implications of these findings at the cellular level, the miner¬ alocorticoid effector mechanism was investigated in HML of patients with primary aldosteronism.
Patients and MethodsPatients Six patients with primary aldosteronism (4 males, 2 females; mean age ± SD 50.5 ± 7.6 years) were studied. Important clinical data and laboratory findings are summarized in Table 1. The diagnosis was suspected because of mild hypertension, mild hypokalaemia, elev-